Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1972 1
1989 1
1993 2
1994 2
1995 2
1996 1
1998 3
1999 2
2000 2
2001 2
2002 1
2003 3
2004 4
2005 3
2006 2
2007 2
2008 4
2009 7
2010 5
2011 5
2012 1
2013 4
2016 2
2017 4
2018 2
2019 1
2020 2
2021 2
2022 11
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean dft and carcinoma (201 results)?
Antibodies against endogenous retroviruses promote lung cancer immunotherapy.
Ng KW, Boumelha J, Enfield KSS, Almagro J, Cha H, Pich O, Karasaki T, Moore DA, Salgado R, Sivakumar M, Young G, Molina-Arcas M, de Carné Trécesson S, Anastasiou P, Fendler A, Au L, Shepherd STC, Martínez-Ruiz C, Puttick C, Black JRM, Watkins TBK, Kim H, Shim S, Faulkner N, Attig J, Veeriah S, Magno N, Ward S, Frankell AM, Al Bakir M, Lim EL, Hill MS, Wilson GA, Cook DE, Birkbak NJ, Behrens A, Yousaf N, Popat S, Hackshaw A; TRACERx Consortium; CAPTURE Consortium; Hiley CT, Litchfield K, McGranahan N, Jamal-Hanjani M, Larkin J, Lee SH, Turajlic S, Swanton C, Downward J, Kassiotis G. Ng KW, et al. Nature. 2023 Apr;616(7957):563-573. doi: 10.1038/s41586-023-05771-9. Epub 2023 Apr 12. Nature. 2023. PMID: 37046094 Free PMC article.
Blocking CD47 promotes antitumour immunity through CD103(+) dendritic cell-NK cell axis in murine hepatocellular carcinoma model.
Wang S, Wu Q, Chen T, Su R, Pan C, Qian J, Huang H, Yin S, Xie H, Zhou L, Zheng S. Wang S, et al. J Hepatol. 2022 Aug;77(2):467-478. doi: 10.1016/j.jhep.2022.03.011. Epub 2022 Apr 1. J Hepatol. 2022. PMID: 35367532
However, the behaviour of DCs and the potential crosstalk between DCs and natural killer (NK) cells in the hepatocellular carcinoma (HCC) microenvironment after CD47 blockade remain unclear. ...LAY SUMMARY: Hypoxia (low oxygen levels) is prevalent in the hepatocellular …
However, the behaviour of DCs and the potential crosstalk between DCs and natural killer (NK) cells in the hepatocellular carcinoma ( …
Update in collecting duct carcinoma: Current aspects of the clinical and molecular characterization of an orphan disease.
Suarez C, Marmolejo D, Valdivia A, Morales-Barrera R, Gonzalez M, Mateo J, Semidey ME, Lorente D, Trilla E, Carles J. Suarez C, et al. Front Oncol. 2022 Oct 4;12:970199. doi: 10.3389/fonc.2022.970199. eCollection 2022. Front Oncol. 2022. PMID: 36267983 Free PMC article. Review.
Collecting duct renal cell carcinoma (cdRCC), which until recently was thought to arise from the collecting ducts of Bellini in the renal medulla, is a rare and aggressive type of non-clear renal cell carcinoma (ncRCC), accounting for 1% of all renal tumors and with …
Collecting duct renal cell carcinoma (cdRCC), which until recently was thought to arise from the collecting ducts of Bellini in the r …
Dominant cell type analysis predicts head and neck adenoid cystic carcinoma outcomes.
Xuan L, Yuan J, Zhang H, Zhang Y, Liu H. Xuan L, et al. Ann Diagn Pathol. 2022 Feb;56:151867. doi: 10.1016/j.anndiagpath.2021.151867. Epub 2021 Nov 22. Ann Diagn Pathol. 2022. PMID: 34826781 Free article.
Traditional histological grading for predicting adenoid cystic carcinoma (ACC) outcomes is challenging and unreliable. We explored the relationship between dominant cell type (DCT) and outcomes for ACC of the head and neck to develop a new approach to predicting pro …
Traditional histological grading for predicting adenoid cystic carcinoma (ACC) outcomes is challenging and unreliable. We explored th …
Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trial.
Lim SM, Peters S, Ortega Granados AL, Pinto GDJ, Fuentes CS, Lo Russo G, Schenker M, Ahn JS, Reck M, Szijgyarto Z, Huseinovic N, Zografos E, Buss E, Stjepanovic N, O'Donnell S, de Marinis F. Lim SM, et al. Nat Commun. 2023 Nov 11;14(1):7301. doi: 10.1038/s41467-023-42900-4. Nat Commun. 2023. PMID: 37951954 Free PMC article. Clinical Trial.
Median PFS (months [95% CI]) is 8.8 (6.7-10.4) for DCT and 6.7 (4.9-7.1) for PCT (HR 0.70 [95% CI: 0.50-0.98]; data cut-off: 04 August 22). Median OS (months [95% CI]) is 19.4 (14.5-NR) for DCT and 15.9 (11.6-19.3) for PCT (HR 0.75 [95% CI: 0.53-1.05]) (data cut-off …
Median PFS (months [95% CI]) is 8.8 (6.7-10.4) for DCT and 6.7 (4.9-7.1) for PCT (HR 0.70 [95% CI: 0.50-0.98]; data cut-off: 04 Augus …
Comparative Cytotoxic Activity of Wild Harvested Stems and In Vitro-Raised Protocorms of Dendrobium chryseum Rolfe in Human Cervical Carcinoma and Glioblastoma Cell Lines.
Pant B, Joshi PR, Maharjan S, Thakuri LS, Pradhan S, Shah S, Wagner SH, Pant B. Pant B, et al. Adv Pharmacol Pharm Sci. 2021 Jan 6;2021:8839728. doi: 10.1155/2021/8839728. eCollection 2021. Adv Pharmacol Pharm Sci. 2021. PMID: 33506210 Free PMC article.
The comparative cytotoxic activities of the wild and in vitro-raised protocorms were evaluated in human cervical carcinoma (HeLa) and human glioblastoma (U251) cell lines by MTT assay. ...Significant growth inhibition (%) and potent IC(50) values were demonstrated in HeLa …
The comparative cytotoxic activities of the wild and in vitro-raised protocorms were evaluated in human cervical carcinoma (HeLa) and …
Enhancing Laryngeal Spinocellular Carcinoma Image Security with DCT.
Holla R, Suma D. Holla R, et al. Indian J Otolaryngol Head Neck Surg. 2024 Feb;76(1):695-701. doi: 10.1007/s12070-023-04255-6. Epub 2023 Oct 11. Indian J Otolaryngol Head Neck Surg. 2024. PMID: 38440514
This work proposes a novel secret sharing scheme to enhance the security of Laryngeal Spinocellular Carcinoma or Laryngeal Squamous Cell Carcinoma (LSCC) images using the Discrete Cosine Transformation (DCT) as a cryptographic tool. The DCT-based secre …
This work proposes a novel secret sharing scheme to enhance the security of Laryngeal Spinocellular Carcinoma or Laryngeal Squamous C …
Differentiated thyroid carcinoma in the elderly: influence of age on disease-free and overall survival.
Díez JJ, Anda E, Alcazar V, Isidro ML, Familiar C, Paja M, Rojas Marcos P, Pérez-Corral B, Navarro E, Romero-Lluch AR, Oleaga A, Pamplona MJ, Fernández-García JC, Megía A, Manjón L, Sánchez-Ragnarsson C, Iglesias P, Sastre J. Díez JJ, et al. Endocrine. 2022 Jun;77(1):121-133. doi: 10.1007/s12020-022-03059-y. Epub 2022 May 18. Endocrine. 2022. PMID: 35585463
PURPOSE: We investigated whether age at diagnosis of differentiated thyroid carcinoma (DTC) may be a risk factor for structural disease and mortality after primary treatment in aging patients. METHODS: A multicenter, retrospective analysis including patients older than 60 …
PURPOSE: We investigated whether age at diagnosis of differentiated thyroid carcinoma (DTC) may be a risk factor for structural disea …
Vitamin B6 Metabolic Pathway is Involved in the Pathogenesis of Liver Diseases via Multi-Omics Analysis.
Mei M, Liu D, Tang X, You Y, Peng B, He X, Huang J. Mei M, et al. J Hepatocell Carcinoma. 2022 Aug 11;9:729-750. doi: 10.2147/JHC.S370255. eCollection 2022. J Hepatocell Carcinoma. 2022. PMID: 35979344 Free PMC article.
PURPOSE: To clarify the underlying regulatory mechanisms of progression from liver cirrhosis to hepatocellular carcinoma (HCC), we analyzed the microbiomics, metabolomics, and proteomics in plasma and tissues from patients with HCC or decompensated liver cirrhosis (DC). PA …
PURPOSE: To clarify the underlying regulatory mechanisms of progression from liver cirrhosis to hepatocellular carcinoma (HCC), we an …
Assessment of arterial tumor vascularity in small hepatocellular carcinoma. Comparison between color doppler ultrasonography and radiographic imagings with contrast medium: dynamic CT, angiography, and CT hepatic arteriography.
Furuse J, Maru Y, Yoshino M, Mera K, Sumi H, Sekiguchi R, Satake M, Hasebe T, Ochiai A. Furuse J, et al. Eur J Radiol. 2000 Oct;36(1):20-7. doi: 10.1016/s0720-048x(00)00185-6. Eur J Radiol. 2000. PMID: 10996754
Hepatocellular carcinoma (HCC) is characterized by tumor vascularization from the hepatic artery. ...PDU is superior to CDU, dCT and DSA and equal to CTA for the detection of tumor vascularity in small HCC, particularly in well-differentiated HCC....
Hepatocellular carcinoma (HCC) is characterized by tumor vascularization from the hepatic artery. ...PDU is superior to CDU, dCT …
85 results